HERNDON, Va.--(BUSINESS WIRE)--Guardian Technologies International, Inc. (OTCBB:GDTI), innovators of groundbreaking medical imaging and threat detection technology with critical and immediate applications for the healthcare and homeland security markets, has announced the successful completion of a clinical study involving the evaluation of its Signature Mapping™ software solution product to a well-know and clearly defined online database of mammographic x-ray exams known as the DDSM Project.
